The National Agency for Science and Engineering Infrastructure (NASENI) has reaffirmed its commitment to strengthening the healthcare sector of NIgeria through the local production of medical diagnostic technologies.
Speaking in Abuja, Khalil Suleiman Halilu said the agency’s biotechnology facility was established to reduce dependence on imported diagnostic kits and enhance Nigeria’s healthcare manufacturing capacity.
The remarks came after participants in the Harvard University-led Science of Defeating Malaria programme toured the NASENI-Troment Biotechnologies factory and commended its contribution to healthcare innovation and disease control. The delegation, led by Dyann Wirth, included about 85 health professionals, scientists, and policymakers from around the world.
According to NASENI, the facility manufactures rapid diagnostic tests and in-vitro diagnostic products for conditions including malaria, hepatitis B and C, HIV, typhoid, syphilis, COVID-19, pregnancy testing, and blood glucose monitoring. The agency says the factory is designed to produce up to 600 million diagnostic kits annually, enough to meet a substantial share of domestic demand while supporting exports to other African markets.
Stakeholders believe that local production can improve healthcare resilience, reduce import dependence, create jobs, and strengthen Nigeria’s position in Africa’s growing health technology sector.
NASENI plans to continue expanding local healthcare manufacturing as part of its strategy to promote science, technology, and innovation. The agency hopes the biotechnology facility will support disease control efforts, boost industrial capacity, and position Nigeria as a leading healthcare manufacturing hub in Africa.
UK plans social media ban for children under 16
June 15, 2026
